°ñÀ¯µµ Àç»ý¼ú(GBR) ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2024-2033³â)
Guided Bone Regeneration Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Persistence Market Research´Â ÃÖ±Ù °ñÀ¯µµ Àç»ý¼ú(GBR) ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ º¸°í¼¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ º¸°í¼´Â ÁÖ¿ä ½ÃÀå ¿ªÇп¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®À» ÅëÇØ ½ÃÀå Àü¸ÁÀ» Çü¼ºÇÏ´Â ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ ¹× °úÁ¦¿¡ ´ëÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.
ÁÖ¿ä ÀλçÀÌÆ®
°ñÀ¯µµ Àç»ý¼ú(GBR) ½ÃÀå ±Ô¸ð(2024³â) : 7¾ï 9,140¸¸ ´Þ·¯
2033³â ¿¹»ó ½ÃÀå ±Ô¸ð(2033³â) : 12¾ï ´Þ·¯
¼¼°è ½ÃÀå ¼ºÀå·ü(2024-2033³â CAGR) : 4.7%
°ñÀ¯µµ Àç»ý¼ú(GBR) ½ÃÀå - Á¶»ç ¹üÀ§
°ñ À¯µµ Àç»ý(GBR) ±â¼úÀº ±¹¼Ò °á¼Õ ºÎÀ§ÀÇ »À Á¶Á÷ Àç»ýÀ» ÃËÁøÇÔÀ¸·Î½á Àç»ý Ä¡°ú ¹× Á¤Çü¿Ü°ú¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. GBR ½ÃÀåÀº Ä¡°ú, º´¿ø ¹× Á¤Çü¿Ü°ú ¼¾Å͸¦ ´ë»óÀ¸·Î ´Ù¾çÇÑ ÀÓ»óÀû ¿ëµµ¿¡ ¸Â´Â ´Ù¾çÇÑ »ýü Àç·á, ¸âºê·¹ÀÎ ¹× ¼ö¼ú±â±¸¸¦ Á¦°øÇÏ´Â ´Ù¾çÇÑ »ýü Àç·á, ¸âºê·¹ÀÎ ¹× ¼ö¼ú±â±¸¸¦ Á¦°øÇÕ´Ï´Ù. Á¦°øÇÕ´Ï´Ù.
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
¼¼°è °ñÀ¯µµ Àç»ý¼ú(GBR) ½ÃÀåÀº Ä¡ÁÖÁúȯÀÇ À¯º´·ü Áõ°¡, ¿Ü»ó ¹× Áúº´À¸·Î ÀÎÇÑ »À °á¼Õ ¹ß»ý·ü Áõ°¡, »À °ü·Ã Áúȯ¿¡ Ãë¾àÇÑ °í·ÉÈ Àα¸ Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. »ýü Àç·á, ¸âºê·¹ÀÎ µðÀÚÀÎ, ÃÖ¼Ò Ä§½À ¼ö¼ú ±â¼úÀÇ ±â¼ú ¹ßÀüÀº Ä¡·á °á°ú¿Í ȯÀÚ È¸º¹À» Çâ»ó½ÃÄÑ ½ÃÀå È®´ë¸¦ ÃËÁøÇÒ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, Ä¡°ú ¹× Á¤Çü¿Ü°ú Àü¹® ºÐ¾ß»Ó¸¸ ¾Æ´Ï¶ó ¾Ç¾È¸é ¼ö¼ú ¹× ¼öÀÇÇп¡ ´ëÇÑ GBR ±â¼úÀÇ Àû¿ë È®´ë´Â ½ÃÀå ±â¾÷¿¡°Ô »õ·Î¿î ¼ºÀå ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
À¯¸ÁÇÑ ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸Çϰí, °ñÀ¯µµ Àç»ý¼ú(GBR)ÀÇ·á ½ÃÀåÀº °í°¡ÀÇ Ä¡·áºñ, Á¦ÇÑÀûÀÎ »óȯ ¹üÀ§, »ýüÀç·á ¹× ÀÇ·á±â±âÀÇ ½ÂÀÎ ¹× »ó¿ëȸ¦ °ü¸®ÇÏ´Â º¹ÀâÇÑ ±ÔÁ¦¿Í °ü·ÃµÈ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç°ú Áö¿ªº°·Î »óÀÌÇÑ ÀÇ·á Á¤Ã¥Àº Á¦Á¶¾÷ü¿Í ÀÇ·á ¼ºñ½º Á¦°ø¾÷ü¿¡°Ô ÄÄÇöóÀ̾𽺠ºÎ´ãÀ» °¡Áß½ÃÄÑ ½ÃÀå ħÅõ¿Í »ç¾÷ Àü·«¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù.
½ÃÀå ±âȸ
°ñÀ¯µµ Àç»ý¼ú(GBR)ÀÇ·á ½ÃÀåÀº ÇöÀç ÁøÇà ÁßÀÎ ¿¬±¸°³¹ß Ȱµ¿, Àü·«Àû Á¦ÈÞ, ½ÅÈï±¹°¡ÀÇ ÀÇ·á ÀÎÇÁ¶ó È®´ë·Î ÀÎÇØ Å« ¼ºÀå ±âȸ¸¦ ¸ÂÀÌÇϰí ÀÖ½À´Ï´Ù. »ýü ÀûÇÕ¼º Àç·á, ¸ÂÃãÇü ÀÓÇöõÆ®¿ë 3D ÇÁ¸°ÆÃ ±â¼ú, µðÁöÅÐ Ä¡°ú ¼Ö·ç¼ÇÀÇ Çõ½ÅÀº Ä¡·á Á¤È®µµ¿Í ȯÀÚ °á°ú¸¦ Çâ»ó½ÃÄÑ ½ÃÀå ¼ö¿ä¸¦ ÀÚ±ØÇÒ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, ¿ø°Ý ÀÇ·á Ç÷§Æû°ú µðÁöÅÐ Çコ ±â¼úÀÇ ÅëÇÕÀº ȯÀÚÀÇ ¿ø°Ý ¸ð´ÏÅ͸µ°ú ¼ö¼ú ÈÄ °ü¸® °ü¸®¸¦ ¿ëÀÌÇÏ°Ô ÇÏ¿© Ä¡·á ¼øÀÀµµ¿Í ÀÓ»ó °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå °³¿ä
½ÃÀå ¹üÀ§/ºÐ·ù
½ÃÀåÀÇ Á¤ÀÇ/¹üÀ§/Á¦ÇÑ
Æ÷ÇÔ »çÇס¤Á¦¿Ü »çÇ×
Á¦3Àå ÁÖ¿ä ½ÃÀå µ¿Çâ
½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä µ¿Çâ
°³¹ß µ¿Çâ
Á¦4Àå ÁÖ¿ä ³»¿ë
Á¦Ç° äÅà ºÐ¼® : Áö¿ªº°
Á¦Ç° USP ºÐ¼®
ÁÖ¿ä ÇÁ·Î¸ð¼Ç Àü·« : Á¦Á¶¾÷üº°
±ÔÁ¦ ½Ã³ª¸®¿À
PESTLE ºÐ¼®
PorterÀÇ Five Forces ºÐ¼®
¹ë·ùüÀÎ ºÐ¼®
Á¦5Àå ½ÃÀå ¹è°æ
°Å½Ã°æÁ¦ ¿äÀÎ
¿¹Ãø ¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ
½ÃÀå ¿ªÇÐ
Á¦6Àå COVID-19 À§±â ºÐ¼®
2024³â ½ÃÀå ½Ã³ª¸®¿À
COVID-19¿Í ¿µÇ⠺м®
Àç·áº°
¿ëµµº°
ÃÖÁ¾»ç¿ëÀÚº°
Áö¿ªº°
Á¦7Àå ¼¼°èÀÇ °ñÀ¯µµ Àç»ý¼ú(GBR) ½ÃÀå ¼ö¿ä(¼ö·®) ºÐ¼®
°ú°Å ½ÃÀå ¼ö·® ºÐ¼®, 2019³â-2023³â
ÇöÀç ¹× ÇâÈÄ ½ÃÀå ¼ö·® ¿¹Ãø, 2024³â-2033³â
Á¦8Àå ¼¼°èÀÇ °ñÀ¯µµ Àç»ý¼ú(GBR) ½ÃÀå - °¡°Ý ºÐ¼®
Áö¿ªº° °¡°Ý ºÐ¼® : Àç·áº°
°¡°Ý ºÐ¼®
Á¦Á¶¾÷ü ·¹º§
À¯Åë¾÷ü ·¹º§
¼¼°è Æò±Õ °¡°Ý ºÐ¼® º¥Ä¡¸¶Å©
°¡°Ý °áÁ¤ÀÇ ÀüÁ¦Á¶°Ç
Á¦9Àå ¼¼°èÀÇ °ñÀ¯µµ Àç»ý¼ú(GBR) ½ÃÀå ¼ö¿ä(±Ý¾× ¶Ç´Â ±Ô¸ð, ¹é¸¸ ´Þ·¯) ºÐ¼®
°ú°Å ½ÃÀå ¸ÅÃâ(¹é¸¸ ´Þ·¯) ºÐ¼®, 2019³â-2023³â
ÇöÀç ¹× ÇâÈÄ ½ÃÀå ¸ÅÃâ(¹é¸¸ ´Þ·¯) ¿¹Ãø, 2024³â-2033³â
Àü³â´ëºñ ¼ºÀå µ¿Ç⠺м®
Àý´ë¾× ±âȸ ºÐ¼®
Á¦10Àå ¼¼°èÀÇ °ñÀ¯µµ Àç»ý¼ú(GBR) ½ÃÀå ºÐ¼® : Àç·áº°
¼·Ð/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·® ºÐ¼® : Àç·áº°, 2019³â-2023³â
ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·® ºÐ¼®°ú ¿¹Ãø : Àç·áº°, 2024³â-2033³â
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Àç·áº°
Á¦11Àå ¼¼°èÀÇ °ñÀ¯µµ Àç»ý¼ú(GBR) ½ÃÀå ºÐ¼® : ¿ëµµº°
¼·Ð/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼® : ¿ëµµº°, 2019³â-2023³â
ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø : ¿ëµµº°, 2024³â-2033³â
ÀÓÇöõÆ®ÇÐ
Ä¡ÁÖÁúȯÇÐ
±¸°¿Ü°ú
±âŸ
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ¿ëµµº°
Á¦12Àå ¼¼°èÀÇ °ñÀ¯µµ Àç»ý¼ú(GBR) ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°
¼·Ð/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°, 2019-2023³â
ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°, 2024³â-2033³â
º´¿ø
Ä¡°úÀÇ¿ø
Çмú¿¬±¸¼¾ÅÍ
¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°
Á¦13Àå ¼¼°èÀÇ °ñÀ¯µµ Àç»ý¼ú(GBR) ½ÃÀå ºÐ¼® : Áö¿ªº°
¼·Ð
°ú°Å ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·® ºÐ¼® : Áö¿ªº°, 2019³â-2023³â
ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(¹é¸¸ ´Þ·¯)¿Í ¼ö·® ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°, 2024³â-2033³â
ºÏ¹Ì
¶óƾ¾Æ¸Þ¸®Ä«
À¯·´
³²¾Æ½Ã¾Æ
µ¿¾Æ½Ã¾Æ
¿À¼¼¾Æ´Ï¾Æ
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Áö¿ªº°
Á¦14Àå ºÏ¹ÌÀÇ °ñÀ¯µµ Àç»ý¼ú(GBR) ½ÃÀå ºÐ¼®
Á¦15Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ °ñÀ¯µµ Àç»ý¼ú(GBR) ½ÃÀå ºÐ¼®
Á¦16Àå À¯·´ÀÇ °ñÀ¯µµ Àç»ý¼ú(GBR) ½ÃÀå ºÐ¼®
Á¦17Àå ³²¾Æ½Ã¾ÆÀÇ °ñÀ¯µµ Àç»ý¼ú(GBR) ½ÃÀå ºÐ¼®
Á¦18Àå µ¿¾Æ½Ã¾ÆÀÇ °ñÀ¯µµ Àç»ý¼ú(GBR) ½ÃÀå ºÐ¼®
Á¦19Àå ¿À¼¼¾Æ´Ï¾ÆÀÇ °ñÀ¯µµ Àç»ý¼ú(GBR) ½ÃÀå ºÐ¼®
Á¦20Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)ÀÇ °ñÀ¯µµ Àç»ý¼ú(GBR) ½ÃÀå ºÐ¼®
Á¦21Àå ½ÃÀå ±¸Á¶ ºÐ¼®
½ÃÀå ºÐ¼® : ±â¾÷ Tierº°
ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
½ÃÀå ÀÔÁö ºÐ¼®
Á¦22Àå °æÀï ºÐ¼®
°æÀï ´ë½Ãº¸µå
°æÀï º¥Ä¡¸¶Å·
°æÀï »ó¼¼ Á¤º¸
Baxter International Inc.
Medtronic
Stryker Corp.
Integra LifeSciences
Zimmer Biomet Holdings
Dentsply Sirona
botiss biomaterials GmbH
Geistlich Pharma AG
Biotech Dental
Dentegris GmbH
GENOSS Co.,Ltd.
Osstem Implant
Á¦23Àå »ç¿ëµÈ ÀüÁ¦Á¶°Ç°ú µÎÀÚ¾î
Á¦24Àå Á¶»ç ¹æ¹ý
LSH
Persistence Market Research has recently released a comprehensive report on the Guided Bone Regeneration (GBR) market. The report provides an in-depth analysis of crucial market dynamics, offering insights into drivers, trends, opportunities, and challenges shaping the market landscape.
Key Insights:
Guided Bone Regeneration Market Size (2024E): USD 791.4 million
Projected Market Value (2033F): USD 1,200.00 million
Global Market Growth Rate (CAGR 2024 to 2033): 4.7%
Guided Bone Regeneration Market - Report Scope:
Guided Bone Regeneration (GBR) techniques play a critical role in regenerative dentistry and orthopedic surgery by facilitating the regeneration of bone tissue in localized defects. These techniques involve the use of barrier membranes and bone graft materials to create a space conducive to bone growth, thereby restoring bone volume and architecture. The GBR market serves dental clinics, hospitals, and orthopedic centers, offering a variety of biomaterials, membranes, and surgical instruments tailored for different clinical applications.
Market Growth Drivers:
The global Guided Bone Regeneration market is driven by several factors, including increasing prevalence of periodontal diseases, rising incidence of bone defects due to trauma or disease, and growing aging population susceptible to bone-related disorders. Technological advancements in biomaterials, membrane designs, and minimally invasive surgical techniques enhance treatment outcomes and patient recovery, fostering market expansion. Moreover, expanding applications of GBR techniques beyond dental and orthopedic specialties into maxillofacial surgery and veterinary medicine create new growth opportunities for market players.
Market Restraints:
Despite promising growth prospects, the Guided Bone Regeneration market faces challenges related to high treatment costs, limited reimbursement coverage, and regulatory complexities governing the approval and commercialization of biomaterials and medical devices. Stringent regulatory requirements and varying healthcare policies across regions impose compliance burdens on manufacturers and healthcare providers, influencing market penetration and operational strategies.
Market Opportunities:
The Guided Bone Regeneration market presents significant growth opportunities driven by ongoing research and development activities, strategic collaborations, and expanding healthcare infrastructure in emerging economies. Innovations in biocompatible materials, 3D printing technologies for customized implants, and digital dentistry solutions enhance treatment precision and patient outcomes, stimulating market demand. Furthermore, the integration of telemedicine platforms and digital health technologies facilitates remote patient monitoring and post-operative care management, improving treatment adherence and clinical outcomes.
Competitive Intelligence and Business Strategy:
Leading players in the global Guided Bone Regeneration market, such as Medtronic,Stryker Corp.,Integra LifeSciences, focus on product innovation, strategic partnerships, and market expansion initiatives to maintain competitive advantage. These companies invest in R&D to develop advanced biomaterials, biodegradable membranes, and patient-specific surgical kits, addressing diverse clinical needs and enhancing treatment efficacy. Collaborations with academic institutions, dental research centers, and regulatory agencies support technology adoption and market access, driving sustainable growth in the dynamic GBR landscape.
Key Questions Answered in the Report:
What are the primary factors driving the growth of the Guided Bone Regeneration market globally?
Which biomaterials and membrane technologies are driving adoption of GBR techniques across dental and orthopedic specialties?
How are technological advancements reshaping the competitive landscape of the Guided Bone Regeneration market?
Who are the key players contributing to the Guided Bone Regeneration market, and what strategies are they employing to sustain market leadership?
What are the emerging trends and future prospects in the global Guided Bone Regeneration market?
Key Companies Profiled
Baxter International Inc.
Medtronic
Stryker Corp.
Integra LifeSciences
Zimmer Biomet Holdings
Dentsply Sirona
botiss biomaterials GmbH
Geistlich Pharma AG
Biotech Dental
Dentegris GmbH
GENOSS Co., Ltd.
Osstem Implant
Guided Bone Regeneration Industry Research Segmentation
By Material:
Bone Graft Substitutes
Barrier Membranes
By Application:
Implantology
Periodontology
Oral and Maxillofacial Surgery
By End User:
Hospitals
Dental Clinics
Academic & Research Centers
Ambulatory Surgical Centers
By Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa (MEA)
Table of Contents
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion And Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Development Trends
4. Key Inclusions
4.1. Product Adoption Analysis by Region
4.2. Product USP Analysis
4.3. Key Promotional Strategies by Manufacturers
4.4. Regulatory Scenario
4.5. PESTLE Analysis
4.6. Porter's Analysis
4.7. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Industry Outlook
5.1.3. Global Bone Regeneration Market Overview
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. Increasing Prevalence of Dental Diseases
5.2.3. Adoption of Minimally Invasive Procedures
5.2.4. Increasing Prevalence of Bone Related disorders
5.2.5. New Product launches and approvals
5.2.6. Regulatory Policies
5.2.7. Historic and Current Revenue of key players
5.2.8. Technology advancements
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. 2024 Market Scenario
6.2. COVID-19 and Impact Analysis
6.2.1. By Material
6.2.2. By Application
6.2.3. By End User
6.2.4. By Region
7. Global Guided Bone Regeneration Market Demand (Volume) Analysis 2019-2023 and Forecast, 2024-2033
7.1. Historical Market Volume ('000 Units) Analysis, 2019-2023
7.2. Current and Future Market Volume ('000 Units) Projections, 2024-2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Guided Bone Regeneration Market - Pricing Analysis
8.1. Regional Pricing Analysis By Material
8.2. Pricing Break Up
8.2.1. Manufacturer Level
8.2.2. Distributor Level
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Guided Bone Regeneration Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033
9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033, By Material
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Material, 2019-2023
10.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Material, 2024-2033
10.3.1. Bone Graft Substitutes
10.3.1.1. Allograft
10.3.1.2. Xenograft
10.3.1.3. Synthetic Bone Graft
10.3.1.4. Others
10.3.2. Barrier Membrane
10.3.2.1. Expanded polytetrafluoroethylene (e-PTFE)
10.3.2.2. High-density polytetrafluoroethylene (d-PTFE)
10.3.2.3. Titanium mesh and titanium-reinforced PTFE
10.4. Market Attractiveness Analysis By Material
11. Global Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033, By Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2023
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2033
11.3.1. Implantology
11.3.2. Periodontology
11.3.3. Oral and Maxillofacial surgery
11.3.4. Others
11.4. Market Attractiveness Analysis By Application
12. Global Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
12.3.1. Hospitals
12.3.2. Dental Clinics
12.3.3. Academic & Research Centers
12.3.4. Ambulatory Surgical Centers
12.4. Market Attractiveness Analysis By End User
13. Global Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033, By Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume ('000 Units)Analysis By Region, 2019-2023
13.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Region, 2024-2033
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East and Africa
13.4. Market Attractiveness Analysis By Region
14. North America Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Material
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Material
14.4.3. By Application
14.4.4. By End User
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
14.7. Country Level Analysis & Forecast
14.7.1. U.S. Guided Bone Regeneration Market
14.7.1.1. Introduction
14.7.1.2. Market Analysis and Forecast by Market Taxonomy
14.7.1.2.1. By Material
14.7.1.2.2. By Application
14.7.1.2.3. By End User
14.7.2. Canada Guided Bone Regeneration Market
14.7.2.1. Introduction
14.7.2.2. Market Analysis and Forecast by Market Taxonomy
14.7.2.2.1. By Material
14.7.2.2.2. By Application
14.7.2.2.3. By End User
15. Latin America Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Material
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Material
15.4.3. By Application
15.4.4. By End User
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
15.7. Country Level Analysis & Forecast
15.7.1. Brazil Guided Bone Regeneration Market
15.7.1.1. Introduction
15.7.1.2. Market Analysis and Forecast by Market Taxonomy
15.7.1.2.1. By Material
15.7.1.2.2. By Application
15.7.1.2.3. By End User
15.7.2. Mexico Portable Multi-Parameter Monitors Market
15.7.2.1. Introduction
15.7.2.2. Market Analysis and Forecast by Market Taxonomy
15.7.2.2.1. By Material
15.7.2.2.2. By Application
15.7.2.2.3. By End User
15.7.3. Argentina Guided Bone Regeneration Market
15.7.3.1. Introduction
15.7.3.2. Market Analysis and Forecast by Market Taxonomy
15.7.3.2.1. By Material
15.7.3.2.2. By Application
15.7.3.2.3. By End User
16. Europe Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Russia
16.3.1.8. Nordic Countries
16.3.1.9. Rest of Europe
16.3.2. By Material
16.3.3. By Portability
16.3.4. By Application
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Material
16.4.3. By Application
16.4.4. By End User
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
16.7. Country Level Analysis & Forecast
16.7.1. Germany Guided Bone Regeneration Market
16.7.1.1. Introduction
16.7.1.2. Market Analysis and Forecast by Market Taxonomy
16.7.1.2.1. By Material
16.7.1.2.2. By Application
16.7.1.2.3. By End User
16.7.2. Italy Guided Bone Regeneration Market
16.7.2.1. Introduction
16.7.2.2. Market Analysis and Forecast by Market Taxonomy
16.7.2.2.1. By Material
16.7.2.2.2. By Application
16.7.2.2.3. By End User
16.7.3. France Guided Bone Regeneration Market
16.7.3.1. Introduction
16.7.3.2. Market Analysis and Forecast by Market Taxonomy
16.7.3.2.1. By Material
16.7.3.2.2. By Application
16.7.3.2.3. By End User
16.7.4. U.K. Guided Bone Regeneration Market
16.7.4.1. Introduction
16.7.4.2. Market Analysis and Forecast by Market Taxonomy
16.7.4.2.1. By Material
16.7.4.2.2. By Application
16.7.4.2.3. By End User
16.7.5. Spain Guided Bone Regeneration Market
16.7.5.1. Introduction
16.7.5.2. Market Analysis and Forecast by Market Taxonomy
16.7.5.2.1. By Material
16.7.5.2.2. By Application
16.7.5.2.3. By End User
16.7.6. BENULUX Guided Bone Regeneration Market
16.7.6.1. Introduction
16.7.6.2. Market Analysis and Forecast by Market Taxonomy
16.7.6.2.1. By Material
16.7.6.2.2. By Application
16.7.6.2.3. By End User
16.7.7. Russia Guided Bone Regeneration Market
16.7.7.1. Introduction
16.7.7.2. Market Analysis and Forecast by Market Taxonomy
16.7.7.2.1. By Material
16.7.7.2.2. By Application
16.7.7.2.3. By End User
16.7.8. Nordic Countries Guided Bone Regeneration Market
16.7.8.1. Introduction
16.7.8.2. Market Analysis and Forecast by Market Taxonomy
16.7.8.2.1. By Material
16.7.8.2.2. By Application
16.7.8.2.3. By End User
17. South Asia Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Indonesia
17.3.1.3. Malaysia
17.3.1.4. Thailand
17.3.1.5. Rest of South Asia
17.3.2. By Material
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Material
17.4.3. By Application
17.4.4. By End User
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
17.7. Country Level Analysis & Forecast
17.7.1. India Guided Bone Regeneration Market
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast by Market Taxonomy
17.7.1.2.1. By Material
17.7.1.2.2. By Application
17.7.1.2.3. By End User
17.7.2. Indonesia Guided Bone Regeneration Market
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast by Market Taxonomy
17.7.2.2.1. By Material
17.7.2.2.2. By Application
17.7.2.2.3. By End User
17.7.3. Malaysia Guided Bone Regeneration Market
17.7.3.1. Introduction
17.7.3.2. Market Analysis and Forecast by Market Taxonomy
17.7.3.2.1. By Material
17.7.3.2.2. By Application
17.7.3.2.3. By End User
17.7.4. Thailand Guided Bone Regeneration Market
17.7.4.1. Introduction
17.7.4.2. Market Analysis and Forecast by Market Taxonomy
17.7.4.2.1. By Material
17.7.4.2.2. By Application
17.7.4.2.3. By End User
18. East Asia Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
18.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Material
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Material
18.4.3. By Application
18.4.4. By End User
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
18.7. Country Level Analysis & Forecast
18.7.1. China Guided Bone Regeneration Market
18.7.1.1. Introduction
18.7.1.2. Market Analysis and Forecast by Market Taxonomy
18.7.1.2.1. By Material
18.7.1.2.2. By Application
18.7.1.2.3. By End User
18.7.2. Japan Guided Bone Regeneration Market
18.7.2.1. Introduction
18.7.2.2. Market Analysis and Forecast by Market Taxonomy
18.7.2.2.1. By Material
18.7.2.2.2. By Application
18.7.2.2.3. By End User
18.7.3. South Korea Guided Bone Regeneration Market
18.7.3.1. Introduction
18.7.3.2. Market Analysis and Forecast by Market Taxonomy
18.7.3.2.1. By Material
18.7.3.2.2. By Application
18.7.3.2.3. By End User
19. Oceania Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033
19.1. Introduction
19.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
19.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Material
19.3.3. By Application
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Material
19.4.3. By Application
19.4.4. By End User
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
19.7. Country Level Analysis & Forecast
19.7.1. Australia Guided Bone Regeneration Market
19.7.1.1. Introduction
19.7.1.2. Market Analysis and Forecast by Market Taxonomy
19.7.1.2.1. By Material
19.7.1.2.2. By Application
19.7.1.2.3. By End User
19.7.2. New Zealand Guided Bone Regeneration Market
19.7.2.1. Introduction
19.7.2.2. Market Analysis and Forecast by Market Taxonomy
19.7.2.2.1. By Material
19.7.2.2.2. By Application
19.7.2.2.3. By End User
20. Middle East and Africa (MEA) Guided Bone Regeneration Market Analysis 2019-2023 and Forecast 2024-2033
20.1. Introduction
20.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis By Market Taxonomy, 2019-2023
20.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2033
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. North Africa
20.3.1.4. South Africa
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Material
20.3.3. By Application
20.3.4. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Material
20.4.3. By Application
20.4.4. By End User
20.5. Key Market Participants - Intensity Mapping
20.6. Drivers and Restraints - Impact Analysis
20.7. Country Level Analysis & Forecast
20.7.1. GCC Countries Guided Bone Regeneration Market
20.7.1.1. Introduction
20.7.1.2. Market Analysis and Forecast by Market Taxonomy
20.7.1.2.1. By Material
20.7.1.2.2. By Application
20.7.1.2.3. By End User
20.7.2. Turkey Guided Bone Regeneration Market
20.7.2.1. Introduction
20.7.2.2. Market Analysis and Forecast by Market Taxonomy
20.7.2.2.1. By Material
20.7.2.2.2. By Application
20.7.2.2.3. By End User
20.7.3. North Africa Guided Bone Regeneration Market
20.7.3.1. Introduction
20.7.3.2. Market Analysis and Forecast by Market Taxonomy
20.7.3.2.1. By Material
20.7.3.2.2. By Application
20.7.3.2.3. By End User
20.7.4. South Africa Guided Bone Regeneration Market
20.7.4.1. Introduction
20.7.4.2. Market Analysis and Forecast by Market Taxonomy
20.7.4.2.1. By Material
20.7.4.2.2. By Application
20.7.4.2.3. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
21.3.1. Regional footprint of Players
21.3.2. Material footprint by Players
21.3.3. Channel footprint by Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Baxter International Inc.
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.1.4. Sales Footprint
22.3.1.5. SWOT Analysis
22.3.1.6. Key Developments
22.3.1.7. Strategy Overview
22.3.1.7.1. Channel Strategy
22.3.1.7.2. Marketing Strategy
22.3.1.7.3. Material Strategy
22.3.2. Medtronic
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.2.4. Sales Footprint
22.3.2.5. SWOT Analysis
22.3.2.6. Key Developments
22.3.2.7. Strategy Overview
22.3.2.7.1. Channel Strategy
22.3.2.7.2. Marketing Strategy
22.3.2.7.3. Material Strategy
22.3.3. Stryker Corp.
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.3.4. Sales Footprint
22.3.3.5. SWOT Analysis
22.3.3.6. Key Developments
22.3.3.7. Strategy Overview
22.3.3.7.1. Channel Strategy
22.3.3.7.2. Marketing Strategy
22.3.3.7.3. Material Strategy
22.3.4. Integra LifeSciences
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.4.4. Sales Footprint
22.3.4.5. SWOT Analysis
22.3.4.6. Key Developments
22.3.4.7. Strategy Overview
22.3.4.7.1. Channel Strategy
22.3.4.7.2. Marketing Strategy
22.3.4.7.3. Material Strategy
22.3.5. Zimmer Biomet Holdings
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.5.4. Sales Footprint
22.3.5.5. SWOT Analysis
22.3.5.6. Key Developments
22.3.5.7. Strategy Overview
22.3.5.7.1. Channel Strategy
22.3.5.7.2. Marketing Strategy
22.3.5.7.3. Material Strategy
22.3.6. Dentsply Sirona
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.6.4. Sales Footprint
22.3.6.5. SWOT Analysis
22.3.6.6. Key Developments
22.3.6.7. Strategy Overview
22.3.6.7.1. Channel Strategy
22.3.6.7.2. Marketing Strategy
22.3.6.7.3. Material Strategy
22.3.7. botiss biomaterials GmbH
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.7.4. Sales Footprint
22.3.7.5. SWOT Analysis
22.3.7.6. Key Developments
22.3.7.7. Strategy Overview
22.3.7.7.1. Channel Strategy
22.3.7.7.2. Marketing Strategy
22.3.7.7.3. Material Strategy
22.3.8. Geistlich Pharma AG
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.8.4. Sales Footprint
22.3.8.5. SWOT Analysis
22.3.8.6. Key Developments
22.3.8.7. Strategy Overview
22.3.8.7.1. Channel Strategy
22.3.8.7.2. Marketing Strategy
22.3.8.7.3. Material Strategy
22.3.9. Biotech Dental
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.9.4. Sales Footprint
22.3.9.5. SWOT Analysis
22.3.9.6. Key Developments
22.3.9.7. Strategy Overview
22.3.9.7.1. Channel Strategy
22.3.9.7.2. Marketing Strategy
22.3.9.7.3. Material Strategy
22.3.10. Dentegris GmbH
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.10.4. Sales Footprint
22.3.10.5. SWOT Analysis
22.3.10.6. Key Developments
22.3.10.7. Strategy Overview
22.3.10.7.1. Channel Strategy
22.3.10.7.2. Marketing Strategy
22.3.10.7.3. Material Strategy
22.3.11. GENOSS Co.,Ltd.
22.3.11.1. Overview
22.3.11.2. Product Portfolio
22.3.11.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.11.4. Sales Footprint
22.3.11.5. SWOT Analysis
22.3.11.6. Key Developments
22.3.11.7. Strategy Overview
22.3.11.7.1. Channel Strategy
22.3.11.7.2. Marketing Strategy
22.3.11.7.3. Material Strategy
22.3.12. Osstem Implant
22.3.12.1. Overview
22.3.12.2. Product Portfolio
22.3.12.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.12.4. Sales Footprint
22.3.12.5. SWOT Analysis
22.3.12.6. Key Developments
22.3.12.7. Strategy Overview
22.3.12.7.1. Channel Strategy
22.3.12.7.2. Marketing Strategy
22.3.12.7.3. Material Strategy
23. Assumptions and Acronyms Used
24. Research Methodology